Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 4/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30879536 | 1.00 | TSHR (0.43) | TSHROPRM1LMNADNM1THRB | |
| SCHEMBL20530377 | 1.00 | TSHR (0.43) | TSHROPRM1LMNADNM1THRB | |
| Hydrochloric Acid SCHEMBL30889331 | 0.97 | TSHR (0.42) | TSHROPRM1LMNADNM1THRB | |
| SCHEMBL31294445 | 0.97 | TSHR (0.42) | TSHROPRM1LMNADNM1THRB | |
| SCHEMBL29062998 | 0.97 | TSHR (0.42) | TSHROPRM1LMNADNM1THRB | |
| SCHEMBL16760715 | 0.97 | TSHR (0.42) | TSHROPRM1LMNADNM1THRB | |
| SCHEMBL11153202 | 0.97 | TSHR (0.42) | TSHROPRM1LMNADNM1THRB | |
| SCHEMBL10167940 | 0.97 | TSHR (0.42) | TSHROPRM1LMNADNM1THRB | |
| SCHEMBL3451185 | 0.97 | TSHR (0.42) | TSHROPRM1LMNADNM1THRB | |
| SCHEMBL14534536 | 0.97 | TSHR (0.42) | TSHROPRM1LMNADNM1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| CN-117881397-A | Heterocyclic compounds and methods of use | 安进公司 | 2024-04-12 | — | — | CN | claimed |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2024-02-15 | — | — | US | claimed |
| WO-2023247604-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| US-20230060897-A1 | COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF RAW MATERIAL MALODOURS IN SOAP BASES | FIRMENICH SA (CH) | 2023-03-02 | — | — | US | claimed |
| EP-4106718-A1 | ANTIMICROBIAL COMPOSITIONS | Firmenich SA (CH) | 2022-12-28 | — | — | EP | claimed |
| EP-4096618-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2022-12-07 | — | — | EP | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160089464-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049404-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090557-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20130164239-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2013-06-27 | — | — | US | claimed |
| US-20100028288-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2010-02-04 | — | — | US | claimed |
| EP-2059265-A2 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | Firmenich S.A. (CH) | 2009-05-20 | — | — | EP | claimed |
| WO-2008026140-A2 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2008-03-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130164239-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | NOX5, CUTA, SMURF1 | TSHR 2551/4885OPRM1 70/4885LMNA 4354/4885 |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | OR10J3, OR51E2, MAL2 | TSHR 4469/4885OPRM1 6/4885LMNA 3527/4885 |
| US-20100028288-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | MYOC, AOC1, CUTA | TSHR 1615/4885OPRM1 41/4885LMNA 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.